Listed

Biotricity Inc.

BTCYOTCCIK 1630113HealthcareFiscal year ends Mar 31

Latest reported revenue, Q1 FY2027$4.3mRevenue, Q1 FY2027, three months to 2026-06-30$4.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 19, 2026.

Latest quarter: Q1 FY2027

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$4.3mRevenue, Q1 FY2027, three months to 2026-06-30$4.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure+10.4% on a year earlier
  • Gross margin82.6%Gross margin, Q1 FY2027, three months to 2026-06-30. gross profit / revenueGross profit: $3.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Revenue: $4.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure+2.1 pts on a year earlier
  • Operating margin3.7%Operating margin, Q1 FY2027, three months to 2026-06-30. operating income / revenueOperating income: $158.1k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Revenue: $4.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure−3.6 pts on a year earlier
  • Net margin−22.4%Net margin, Q1 FY2027, three months to 2026-06-30. net income / revenueNet income: −$959.5k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Revenue: $4.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure−5.1 pts on a year earlier
  • Diluted EPS−$0.05Diluted EPS, Q1 FY2027, three months to 2026-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure−58.6% on a year earlier
  • Free cash flownot reported (Capital expenditure not reported)No year-earlier figure to compare

Last eight quarters

Full statements
Revenue$4.3mGross margin 82.6%
Diluted EPS−$0.05, Q1 FY2027
Biotricity Inc., key figures for the last eight quarters
Line itemUnitQ2 FY20252024-09-30Q3 FY20252024-12-31Q4 FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31Q4 FY20262026-03-31Q1 FY20272026-06-30Shape over the periods
Revenue$k3,267Revenue, Q2 FY2025, three months to 2024-09-30$3.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure3,619Revenue, Q3 FY2025, three months to 2024-12-31$3.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure3,703Revenue, Q4 FY2025, three months to 2025-03-31$3.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure3,874Revenue, Q1 FY2026, three months to 2025-06-30$3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure3,886Revenue, Q2 FY2026, three months to 2025-09-30$3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure3,988Revenue, Q3 FY2026, three months to 2025-12-31$4.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure4,251Revenue, Q4 FY2026, three months to 2026-03-31$4.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure4,277Revenue, Q1 FY2027, three months to 2026-06-30$4.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure
Gross margin%75.3%Gross margin, Q2 FY2025, three months to 2024-09-30. gross profit / revenueGross profit: $2.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Revenue: $3.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure76.4%Gross margin, Q3 FY2025, three months to 2024-12-31. gross profit / revenueGross profit: $2.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Revenue: $3.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure80.4%Gross margin, Q4 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $3.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Revenue: $3.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure80.5%Gross margin, Q1 FY2026, three months to 2025-06-30. gross profit / revenueGross profit: $3.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Revenue: $3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure81.9%Gross margin, Q2 FY2026, three months to 2025-09-30. gross profit / revenueGross profit: $3.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Revenue: $3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure81.5%Gross margin, Q3 FY2026, three months to 2025-12-31. gross profit / revenueGross profit: $3.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Revenue: $4.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure80.0%Gross margin, Q4 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $3.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Revenue: $4.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure82.6%Gross margin, Q1 FY2027, three months to 2026-06-30. gross profit / revenueGross profit: $3.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Revenue: $4.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure
Operating margin%(9.4%)Operating margin, Q2 FY2025, three months to 2024-09-30. operating income / revenueOperating income: −$307.7k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Revenue: $3.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure(4.7%)Operating margin, Q3 FY2025, three months to 2024-12-31. operating income / revenueOperating income: −$169.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Revenue: $3.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure(23.1%)Operating margin, Q4 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$855.5k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Revenue: $3.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure7.3%Operating margin, Q1 FY2026, three months to 2025-06-30. operating income / revenueOperating income: $281.9k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Revenue: $3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure7.0%Operating margin, Q2 FY2026, three months to 2025-09-30. operating income / revenueOperating income: $273.8k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Revenue: $3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure11.1%Operating margin, Q3 FY2026, three months to 2025-12-31. operating income / revenueOperating income: $440.9k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Revenue: $4.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure16.3%Operating margin, Q4 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $694.6k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Revenue: $4.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure3.7%Operating margin, Q1 FY2027, three months to 2026-06-30. operating income / revenueOperating income: $158.1k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Revenue: $4.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure
Net margin%(47.8%)Net margin, Q2 FY2025, three months to 2024-09-30. net income / revenueNet income: −$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Revenue: $3.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure(34.0%)Net margin, Q3 FY2025, three months to 2024-12-31. net income / revenueNet income: −$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Revenue: $3.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure(52.3%)Net margin, Q4 FY2025, three months to 2025-03-31. net income / revenueNet income: −$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Revenue: $3.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure(17.3%)Net margin, Q1 FY2026, three months to 2025-06-30. net income / revenueNet income: −$672.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Revenue: $3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure(17.8%)Net margin, Q2 FY2026, three months to 2025-09-30. net income / revenueNet income: −$690.9k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Revenue: $3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure(18.0%)Net margin, Q3 FY2026, three months to 2025-12-31. net income / revenueNet income: −$717.1k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Revenue: $4.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figure(7.6%)Net margin, Q4 FY2026, three months to 2026-03-31. net income / revenueNet income: −$324.2k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Revenue: $4.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001493152-26-033207. Derived: 12-month figure less the 9-month figure.Report this figure(22.4%)Net margin, Q1 FY2027, three months to 2026-06-30. net income / revenueNet income: −$959.5k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Revenue: $4.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure
Diluted EPS$ per share(0.07)Diluted EPS, Q2 FY2025, three months to 2024-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure(0.05)Diluted EPS, Q3 FY2025, three months to 2024-12-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figurenot reported (Diluted EPS not reported)(0.03)Diluted EPS, Q1 FY2026, three months to 2025-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure(0.03)Diluted EPS, Q2 FY2026, three months to 2025-09-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001493152-25-023361.Report this figure(0.04)Diluted EPS, Q3 FY2026, three months to 2025-12-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-11, accession 0001493152-26-006211.Report this figurenot reported (Diluted EPS not reported)(0.05)Diluted EPS, Q1 FY2027, three months to 2026-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-19, accession 0001493152-26-039209.Report this figure
Free cash flow$knot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$16.0mGross margin 80.9%
Diluted EPS−$0.12, FY2026
Free cash flow−$15.2m, FY2022
Biotricity Inc., key figures for the last five fiscal years
Line itemUnitFY20222022-03-31FY20232023-03-31FY20242024-03-31FY20252025-03-31FY20262026-03-31Shape over the periods
Revenue$m7.7Revenue, FY2022, twelve months to 2022-03-31$7.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-06-29, accession 0001493152-23-022974.Report this figure9.6Revenue, FY2023, twelve months to 2023-03-31$9.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-06-27, accession 0001493152-24-025344.Report this figure12.1Revenue, FY2024, twelve months to 2024-03-31$12.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K/A filed 2025-07-18, accession 0001641172-25-020105.Report this figure13.8Revenue, FY2025, twelve months to 2025-03-31$13.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001493152-26-033207.Report this figure16.0Revenue, FY2026, twelve months to 2026-03-31$16.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001493152-26-033207.Report this figure
Gross margin%59.7%Gross margin, FY2022, twelve months to 2022-03-31. gross profit / revenueGross profit: $4.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2023-06-29, accession 0001493152-23-022974.Revenue: $7.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-06-29, accession 0001493152-23-022974.Report this figure56.5%Gross margin, FY2023, twelve months to 2023-03-31. gross profit / revenueGross profit: $5.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-06-27, accession 0001493152-24-025344.Revenue: $9.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-06-27, accession 0001493152-24-025344.Report this figure69.3%Gross margin, FY2024, twelve months to 2024-03-31. gross profit / revenueGross profit: $8.4m. XBRL concept us-gaap:GrossProfit. 10-K/A filed 2025-07-18, accession 0001641172-25-020105.Revenue: $12.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K/A filed 2025-07-18, accession 0001641172-25-020105.Report this figure76.6%Gross margin, FY2025, twelve months to 2025-03-31. gross profit / revenueGross profit: $10.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-07-14, accession 0001493152-26-033207.Revenue: $13.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001493152-26-033207.Report this figure80.9%Gross margin, FY2026, twelve months to 2026-03-31. gross profit / revenueGross profit: $12.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-07-14, accession 0001493152-26-033207.Revenue: $16.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001493152-26-033207.Report this figure
Operating margin%(218.8%)Operating margin, FY2022, twelve months to 2022-03-31. operating income / revenueOperating income: −$16.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-06-29, accession 0001493152-23-022974.Revenue: $7.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-06-29, accession 0001493152-23-022974.Report this figure(159.9%)Operating margin, FY2023, twelve months to 2023-03-31. operating income / revenueOperating income: −$15.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-06-27, accession 0001493152-24-025344.Revenue: $9.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-06-27, accession 0001493152-24-025344.Report this figure(73.2%)Operating margin, FY2024, twelve months to 2024-03-31. operating income / revenueOperating income: −$8.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K/A filed 2025-07-18, accession 0001641172-25-020105.Revenue: $12.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K/A filed 2025-07-18, accession 0001641172-25-020105.Report this figure(17.8%)Operating margin, FY2025, twelve months to 2025-03-31. operating income / revenueOperating income: −$2.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-07-14, accession 0001493152-26-033207.Revenue: $13.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001493152-26-033207.Report this figure10.6%Operating margin, FY2026, twelve months to 2026-03-31. operating income / revenueOperating income: $1.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-07-14, accession 0001493152-26-033207.Revenue: $16.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001493152-26-033207.Report this figure
Net margin%(380.8%)Net margin, FY2022, twelve months to 2022-03-31. net income / revenueNet income: −$29.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2023-06-29, accession 0001493152-23-022974.Revenue: $7.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-06-29, accession 0001493152-23-022974.Report this figure(193.6%)Net margin, FY2023, twelve months to 2023-03-31. net income / revenueNet income: −$18.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-06-27, accession 0001493152-24-025344.Revenue: $9.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-06-27, accession 0001493152-24-025344.Report this figure(116.8%)Net margin, FY2024, twelve months to 2024-03-31. net income / revenueNet income: −$14.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2025-07-18, accession 0001641172-25-020105.Revenue: $12.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K/A filed 2025-07-18, accession 0001641172-25-020105.Report this figure(61.1%)Net margin, FY2025, twelve months to 2025-03-31. net income / revenueNet income: −$8.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-07-14, accession 0001493152-26-033207.Revenue: $13.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001493152-26-033207.Report this figure(15.0%)Net margin, FY2026, twelve months to 2026-03-31. net income / revenueNet income: −$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-07-14, accession 0001493152-26-033207.Revenue: $16.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001493152-26-033207.Report this figure
Diluted EPS$ per sharenot reported (Diluted EPS not reported)(2.26)Diluted EPS, FY2023, twelve months to 2023-03-31−$2.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-06-27, accession 0001493152-24-025344.Report this figure(1.66)Diluted EPS, FY2024, twelve months to 2024-03-31−$1.66 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K/A filed 2025-07-18, accession 0001641172-25-020105.Report this figure(0.56)Diluted EPS, FY2025, twelve months to 2025-03-31−$0.56 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-07-14, accession 0001493152-26-033207.Report this figure(0.12)Diluted EPS, FY2026, twelve months to 2026-03-31−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-07-14, accession 0001493152-26-033207.Report this figure
Free cash flow$m(15.2)Free cash flow, FY2022, twelve months to 2022-03-31. operating cash flow − capital expenditureOperating cash flow: −$15.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-06-29, accession 0001493152-23-022974.Capital expenditure: $29.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-06-29, accession 0001493152-23-022974.Report this figurenot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Dec 2024 to Nov 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Biotricity Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
Strengthening Families & Communities, LLC2026-06-30$6.0k48,263Unchanged

Recent filings

All 317 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Biotricity Inc., recent filings
FiledFormWhat it isAccession number
2026-09-2823:04 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-26-044407
2026-08-1920:05 ET10-QQuarterly reportPeriod 2026-06-300001493152-26-039209
2026-07-1421:25 ET10-KAnnual reportPeriod 2026-03-310001493152-26-033207
2026-05-0121:28 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001493152-26-020939
2026-02-1822:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-26-007369
2026-02-1121:29 ET10-QQuarterly reportPeriod 2025-12-310001493152-26-006211
2025-12-1922:29 ETS-1Registration statement0001493152-25-028614
2025-11-1821:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-25-024061
2025-11-1420:38 ET10-QQuarterly reportPeriod 2025-09-300001493152-25-023361
2025-08-1411:01 ET10-QQuarterly reportPeriod 2025-06-300001641172-25-023709

Latest annual report

Form 10-K for the fiscal year ended Mar 31, 2026Filed Jul 14, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q2 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1630113
Tickers
BTCY
Exchange
OTC
SIC code
3841 Surgical & Medical Instruments & Apparatus
Sector
Healthcare
Fiscal year ends
Mar 31
Incorporated in
NV
Filer category
Non-accelerated filer<br>Smaller reporting company
Former names
METASOLUTIONS, INC. (to 2016-01-05)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.